InnoCare Pharma reports October share capital movements

InnoCare Pharma Limited reported its monthly return for October 2025, detailing movements in its share capital. The total authorized/registered share capital remained at $50,000, with 25 bn ordinary shares at a par value of $0.000002.

The company's issued ordinary shares (excluding treasury shares) saw a decrease of 800,000, bringing the total to 1,493,798,235. Concurrently, treasury shares increased by 800,000, resulting in a total of 2,486,000 treasury shares. These movements contributed to an unchanged total number of issued shares at 1,496,284,235 for the month. Separately, 268,359,717 ordinary shares listed on the Shanghai Stock Exchange remained unchanged, with zero treasury shares.

The decrease in issued shares and corresponding increase in treasury shares were primarily due to the repurchase of 800,000 shares at a price of HK$14.71 on October 10, 2025. Additionally, the company noted that as of the end of October 2025, a total of 703,250 Restricted Shares lapsed under the 2023 RMB Share Incentive Scheme, and 168,000 Restricted Shares lapsed under the 2024 RMB Share Incentive Scheme.